Use of antihypertensive drug classes and combination therapies during the COVID-19 pandemic in Poland: a cross-sectional, nation-wide study 2019-2021
Description
CONCLUSIONS: During the COVID-19 pandemic, a decrease in the frequency of combination treatments and an increase in the frequency of dual and triple SPCs use were observed. Despite the slow increase in the frequency of use of recommended drug
